All News

Patient Access & Engagement

Top 10 Events in Cell & Gene Therapy 2022
18 January 2023
Top 10 Events in Cell & Gene Therapy 2022
It’s day 1 of Advanced
Advanced Therapies Week Countdown: 2022 in Approvals and a Patient-Centric Approach
6 January 2023
Advanced Therapies Week Countdown: 2022 in Approvals and a Patient-Centric Approach
The countdown to Phacilitates Advanced
Advanced Therapies Week Countdown: 5 Agenda Highlights Not to be Missed
16 December 2022
Advanced Therapies Week Countdown: 5 Agenda Highlights Not to be Missed
The Advanced Therapies Week is
Commercial Considerations in the World of Rare Diseases
5 December 2022
Commercial Considerations in the World of Rare Diseases
For this interview, Phacilitate’s Becky
POPULAR NEWS ITEMS
Image
3 February 2023

Navigating the Applications of Title21’s Manufacturing Execution System

Image
2 February 2023

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image
1 February 2023

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer

Creative Mechanisms for Growing the Biomanufacturing Industry
29 November 2022
Creative Mechanisms for Growing the Biomanufacturing Industry
Jenny Ligon, Associate Director of
The New Age of Oncology Treatment and the Patient Experience
28 November 2022
The New Age of Oncology Treatment and the Patient Experience
Courtney Horvath, Global Head of
Harnessing the Biological Power of Cells to Deliver a Therapeutic Product
22 November 2022
Harnessing the Biological Power of Cells to Deliver a Therapeutic Product
For this interview, Phacilitate’s Ryan
Setting the Stage for Successful Clinical Manufacturing of Cell and Gene Therapies
18 October 2022
Setting the Stage for Successful Clinical Manufacturing of Cell and Gene Therapies
Are you preparing to advance
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Navigating the Applications of Title21’s Manufacturing Execution System

Image

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer